雜志介紹

Clinical Psychopharmacology And Neuroscience雜志介紹

《Clinical Psychopharmacology And Neuroscience》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱臨床精神藥理學(xué)和神經(jīng)科學(xué)，本刊主要出版、報道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.4，最新CiteScore 指數(shù)為4.7。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS)

  Author: Liu Shu-Tsen; Lin Sheng-Che; Chang Jane Pei-Chen; Yang Kai-Jie; Chu Che-Sheng; Yang Chia-Chun; Liang Chih-Sung; Sun Ching-Fang; Wang Shao-Cheng; Satyanarayanan, Senthil Kumaran; Su Kuan-Pin

英文介紹

Clinical Psychopharmacology And Neuroscience雜志英文介紹

Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of Neuropsychopharmacology (KCNP), and the associate journal for Asian College of Neuropsychopharmacology (AsCNP). This journal aims to publish evidence-based, scientifically written articles related to clinical and preclinical studies in the field of psychopharmacology and neuroscience. This journal intends to foster and encourage communications between psychiatrist, neuroscientist and all related experts in Asia as well as worldwide. It is published four times a year at the last day of February, May, August, and November.